Jasper Therapeutics, Inc. · NASDAQ:JSPR
Soleus Capital Management, L.P. reported a 9.96% stake in Jasper Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 11, 2025
Soleus Capital Management, L.P. reported a 9.96% stake in Jasper Therapeutics, Inc., 1,494,420 shares, as a passive investor on Dec 31, 2024. Filed Feb 11, 2025 (Schedule 13G/A).
- Stake
- 9.96%
- Shares
- 1,494,420
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Private Equity Fund III, L.P. | 1.30% | 200,000 |
| Soleus Private Equity GP III, LLC | 1.30% | 200,000 |
| Soleus PE GP III, LLC | 1.30% | 200,000 |
| Soleus Capital Master Fund, L.P. | 8.60% | 1,294,420 |
| Soleus Capital, LLC | 8.60% | 1,294,420 |
| Soleus Capital Group, LLC | 8.60% | 1,294,420 |
| Soleus Capital Management, L.P. | 9.96% | 1,494,420 |
| Soleus GP LLC | 9.96% | 1,494,420 |
| Guy Levy | 9.96% | 1,494,420 |
Source
Related
- Jasper Therapeutics, Inc.
- Soleus Capital Master Fund, L.P.
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · May 8, 2026
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026